fep blue cross blue shield glp 1 coverage of Massachusetts will stop covering popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have Identification - Horizon Blue Cross

Resistant starch isnt just more fiber its a targeted signal to the gut that can translate into changes where it matters most: visceral fat

doi: 10.1016/j.neuroscience.2010.08.028 218 MaTDuXPickJESuiGBrownleeMKlannE

Compounders also might see a tailwind from the current political environment

Pfizer has also stated that they plan to sell new medications for the same prices in the US as they charge in other countries (Lupkin, 2025)

When to contact your healthcare provider Not all weight gain on tirzepatide is benign

Electrolyte Solutions: (Generic Pedialyte) Essential for combating the systemic dehydration commonly caused by GLP-1 medications